Insights

Nasal Vaccine Focus BlueWillow Biologics is a clinical-stage biotech developing intranasal vaccines and the NanoVax adjuvant platform, indicating opportunities to discuss partnerships or licensing for nasal vaccine development, mucosal immunity programs, or adjuvant technology collaboration.

Diverse Pipeline The company pursues programs including Peanut Allergy, HSV-2, Covid-19, Anthrax, Pandemic Flu and RSV, suggesting cross-industry collaboration potential with allergen, infectious disease, biodefense, and respiratory disease stakeholders to explore co-development or sponsored research.

Global Immunity Benefit Mucosal and systemic immunity activation positions BlueWillow for strategic partnerships with manufacturers or distributors of vaccines and nasal health solutions, plus opportunities with public health organizations seeking innovative intranasal platforms.

Strategic Partnerships Past collaborations include a Taiwan partner for nasal COVID-19 vaccine and Good360 philanthropic alliance; this track record indicates openness to international partnerships, co-development deals and non-dilutive/supportive collaborations with health-focused NGOs.

Financial Scale Reported revenue range and SBIR/ funding history imply a midsize clinical-stage partner with growth potential; sales outreach can tailor discussions around licensing, milestone-driven collaborations, and research funding to accelerate program advancement.

BlueWillow Biologics, Inc. Tech Stack

BlueWillow Biologics, Inc. uses 8 technology products and services including iCIMS, WordPress, Shopify, and more. Explore BlueWillow Biologics, Inc.'s tech stack below.

iCIMS

Applicant Tracking Systems

WordPress

Content Management System

Shopify

E-commerce

Microsoft 365

JSON-LD

Javascript Frameworks

X-Content-Type-Options

Web & Portal Technology

Piwik PRO Core

Web Analytics

DreamHost

Web Hosting

BlueWillow Biologics, Inc. Email Formats	Example	Percentage
First.Last@bluewillow.com	John.Doe@bluewillow.com	92%
Last@bluewillow.com	Doe@bluewillow.com	8%

BlueWillow Biologics, Inc. Email Formats

Example

Percentage

First.Last@bluewillow.com

John.Doe@bluewillow.com

92%

Last@bluewillow.com

Doe@bluewillow.com

Frequently Asked Questions

What is BlueWillow Biologics, Inc.'s phone number?

You can contact BlueWillow Biologics, Inc.'s main corporate office by phone at

+1-734-302-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BlueWillow Biologics, Inc.'s official website and social media links?

BlueWillow Biologics, Inc.'s official website is bluewillow.com and has social profiles on LinkedIn.

How much revenue does BlueWillow Biologics, Inc. generate?

As of August 2026, BlueWillow Biologics, Inc.'s annual revenue is estimated to be $250M - $500M.

What is BlueWillow Biologics, Inc.'s SIC code and NAICS code?

BlueWillow Biologics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BlueWillow Biologics, Inc. have currently?

As of August 2026, BlueWillow Biologics, Inc. has approximately 22 employees across 2 continents, including North America and Asia. Key team members include Vice President: S. G., Manager: B. W. and Principal: L. H. Explore BlueWillow Biologics, Inc.'s employee directory with LeadIQ.

What industry does BlueWillow Biologics, Inc. belong to?

BlueWillow Biologics, Inc. operates in the Biotechnology Research industry.

What technology does BlueWillow Biologics, Inc. use?

BlueWillow Biologics, Inc.'s tech stack includes iCIMS, WordPress, Shopify, Microsoft 365, JSON-LD, X-Content-Type-Options, Piwik PRO Core and DreamHost.

What is BlueWillow Biologics, Inc.'s email format?

BlueWillow Biologics, Inc.'s email format typically follows the pattern of First.Last@bluewillow.com. Find more BlueWillow Biologics, Inc. email formats with LeadIQ.

How much funding has BlueWillow Biologics, Inc. raised to date?

As of August 2026, BlueWillow Biologics, Inc. has raised $86M in funding. The last funding round occurred on Sep 26, 2018.

BlueWillow Biologics, Inc.

Q: How many employees does BlueWillow Biologics, Inc. have currently?

BlueWillow Biologics, Inc. has approximately 22 employees.

Q: What technology does BlueWillow Biologics, Inc. use?

BlueWillow Biologics, Inc.'s tech stack includes Microsoft PowerPoint, Microsoft Office, Nginx, JSON-LD, Lua.

Q: What is BlueWillow Biologics, Inc.'s NAICS code?

BlueWillow Biologics, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchUnited States11-50 Employees

BlueWillow Biologics, Inc. is a United States-based biotechnology research company focused on developing intranasal vaccines and adjuvants. Its approach aims to stimulate mucosal immunity in the nasal passages while also eliciting systemic immune responses, with a pipeline including Peanut Allergy, HSV-2, Covid-19, Anthrax, Pandemic Flu and RSV. The organization operates at the clinical stage, pursuing safe and effective nasal vaccines to address global health challenges.

In 2022 the company was acquired by LimeWire GmbH. Based in the United States and active in biotechnology research, BlueWillow targets protection from respiratory infections, sexually transmitted diseases, and food allergies through its intranasal vaccine programs.

Insights

Similar companies to BlueWillow Biologics, Inc.

Immune-Onc Therapeutics

CytoDyn Inc.

Osivax

Oncorus